September 1, 2011 | By Ashley Post
The high court's Pliva v. Mensing decision shields generic-medication companies from failure-to-warn claims.
Most Popular Articles
From Merrill DataSite
From Copyright Clearance Center
From Kroll Ontrack
From Bloomberg BNA
From HP Autonomy
From Legal Hold Pro by Zapproved
From Deloitte Discovery
March 17, 2014 at 1:00 pm ET
March 26, 2014 at 2:00 pm ET
Get the latest business trends, current corporate litigation, labor developments, technology initiatives and more.
Sign up to receive InsideScoop — FREE
You have been subscribed! You will receive a confirmation email soon.